Effects of astragalus polysaccharide on intestinal inflammatory damage in goslings infected with gosling plague

1. This study explored the effects of Astragalus membranaceus polysaccharide (APS) on intestinal inflammatory damage of goslings infected with parvovirus ('gosling plague'). 2. A total of 90 healthy goslings were randomly divided into three groups; control, infected or APS treated, respectively. Goslings in the infection and APS treatment groups were inoculated with 0.3 ml allantoic fluid containing goose parvovirus (ELD50 = 1 x 10(3)/0.3 ml) by intramuscular injection and the control group were injected with saline (0.3 ml) twice a day for 15 days. 3. Blood serum and the jejunum were collected at 5, 10 and 15 days after the start of the experiment to detect the activities of SOD and GSH-Px, levels of MDA, sIgA, IL-1 beta, IL-6 and TNF-alpha, the mRNA expression of IL-1 beta, IL-6, LITAF, NF-kappa B, COX-2 and PGE2, pathological damage in the jejunum and serum IgG, IgM, C3, C4, IFN-gamma levels. 4. After APS treatment, SOD and GSH-Px activities increased, MDA content decreased; sIgA, IL-1 beta, IL-6 and TNF-alpha protein content, and IL-1 beta, IL-6, LITAF, NF-kappa B, COX-2 and PGE2 mRNA expression decreased in the jejunal tissue, serum IgG, IgM, C3, C4, IFN-gamma significantly increased and pathological damage of jejunum significantly improved. 5. In conclusion, APS reduced intestinal inflammatory damage in goslings infected with parvovirus by improving the immune and antioxidant functions of goslings.

Automated summary

APS treatment improved the antioxidant capacity and reduced inflammatory damage in goslings infected with parvovirus, indicating its potential as a therapeutic agent for parvovirus infection in young poultry.